{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:50:42Z","timestamp":1791859842719,"version":"4.3.4"},"reference-count":41,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2024,5,22]]},"published-print":{"date-parts":[[2024,8]]},"DOI":"10.2967\/jnumed.123.267151","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T18:11:38Z","timestamp":1720030298000},"page":"1217-1223","source":"Crossref","is-referenced-by-count":16,"title":["The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue,<sup>68<\/sup>Ga-FAPI-46 PET Data, and Survival Data"],"prefix":"10.2967","volume":"65","author":[{"given":"Christoph","family":"Oster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Keyvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Pabst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang P.","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Fragoso Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros","family":"Lazaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Feldheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pierscianek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Ulrich","family":"Schildhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Sure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Ahmadipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kleinschnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Guberina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Deuschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Scheffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sied","family":"Kebir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Glas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"key":"2024080105203385000_65.8.1217.1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-016-1497-x"},{"key":"2024080105203385000_65.8.1217.2","first-page":"26","article-title":"Gliosarcoma case report and review of the literature","volume":"35","author":"Awadalla","year":"2020","journal-title":"Pan Afr Med J."},{"key":"2024080105203385000_65.8.1217.3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106"},{"key":"2024080105203385000_65.8.1217.4","doi-asserted-by":"crossref","first-page":"107146","DOI":"10.1016\/j.clineuro.2022.107146","article-title":"Clinical and survival characteristics of primary and secondary gliosarcoma patients","volume":"214","author":"Amer","year":"2022","journal-title":"Clin Neurol Neurosurg."},{"key":"2024080105203385000_65.8.1217.5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2217\/cns.14.61","article-title":"Therapeutic management of gliosarcoma in the temozolomide era","volume":"4","author":"McAleer","year":"2015","journal-title":"CNS Oncol."},{"key":"2024080105203385000_65.8.1217.6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/jamaoncol.2022.5370","article-title":"Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 prospective externally controlled cohort trial","volume":"9","author":"Liau","year":"2023","journal-title":"JAMA Oncol."},{"key":"2024080105203385000_65.8.1217.7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s42466-022-00184-x","article-title":"AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas","volume":"4","author":"Bunse","year":"2022","journal-title":"Neurol Res Pract."},{"key":"2024080105203385000_65.8.1217.8","doi-asserted-by":"crossref","first-page":"100214","DOI":"10.1016\/j.esmoop.2021.100214","article-title":"Emerging targets for anticancer vaccination: IDH","volume":"6","author":"Platten","year":"2021","journal-title":"ESMO Open."},{"key":"2024080105203385000_65.8.1217.9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrneurol.2017.64","article-title":"Vaccine-based immunotherapeutic approaches to gliomas and beyond","volume":"13","author":"Weller","year":"2017","journal-title":"Nat Rev Neurol."},{"key":"2024080105203385000_65.8.1217.10","doi-asserted-by":"crossref","first-page":"e1191","DOI":"10.1002\/cti2.1191","article-title":"Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy","volume":"9","author":"Ebert","year":"2020","journal-title":"Clin Transl Immunol."},{"key":"2024080105203385000_65.8.1217.11","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.18632\/oncotarget.27389","article-title":"EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma","volume":"10","author":"Ravanpay","year":"2019","journal-title":"Oncotarget."},{"key":"2024080105203385000_65.8.1217.12","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.3390\/cancers13194946","article-title":"FAP and FAPI-PET\/CT in malignant and non-malignant diseases: a perfect symbiosis?","volume":"13","author":"Dendl","year":"2021","journal-title":"Cancers (Basel)."},{"key":"2024080105203385000_65.8.1217.13","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201300095"},{"key":"2024080105203385000_65.8.1217.14","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3390\/cells10051142","article-title":"Oncogenesis, microenvironment modulation and clinical potentiality of FAP in glioblastoma: lessons learned from other solid tumors","volume":"10","author":"Shi","year":"2021","journal-title":"Cells."},{"key":"2024080105203385000_65.8.1217.15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/ijms22031046","article-title":"Regulation of fibroblast activation protein by transforming growth factor beta-1 in glioblastoma microenvironment","volume":"22","author":"Krepela","year":"2021","journal-title":"Int J Mol Sci."},{"key":"2024080105203385000_65.8.1217.16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00418-014-1292-0","article-title":"Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets","volume":"143","author":"Busek","year":"2015","journal-title":"Histochem Cell Biol."},{"key":"2024080105203385000_65.8.1217.17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.51.36505"},{"key":"2024080105203385000_65.8.1217.18","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-194"},{"key":"2024080105203385000_65.8.1217.19","doi-asserted-by":"crossref","first-page":"109021","DOI":"10.1016\/j.ejrad.2020.109021","article-title":"FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas","volume":"127","author":"R\u00f6hrich","year":"2020","journal-title":"Eur J Radiol."},{"key":"2024080105203385000_65.8.1217.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04444-y"},{"key":"2024080105203385000_65.8.1217.21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13550-021-00761-2","article-title":"Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review","volume":"11","author":"Windisch","year":"2021","journal-title":"EJNMMI Res."},{"key":"2024080105203385000_65.8.1217.22","doi-asserted-by":"crossref","first-page":"116600","DOI":"10.1016\/j.bmc.2021.116600","article-title":"In vitro and in\u00a0vivo evaluation of 211At-labeled fibroblast activation protein inhibitor for glioma treatment","volume":"55","author":"Ma","year":"2022","journal-title":"Bioorg Med Chem."},{"key":"2024080105203385000_65.8.1217.23","first-page":"vdad105","article-title":"Are we providing best available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005\u20132022","volume":"5","author":"Oster","year":"2023","journal-title":"Neurooncol Adv."},{"key":"2024080105203385000_65.8.1217.24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.18718"},{"key":"2024080105203385000_65.8.1217.25","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3390\/cancers13133304","article-title":"Fibroblast activation protein expressing mesenchymal cells promote glioblastoma angiogenesis","volume":"13","author":"Balaziova","year":"2021","journal-title":"Cancers (Basel)."},{"key":"2024080105203385000_65.8.1217.26","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1746"},{"key":"2024080105203385000_65.8.1217.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227967"},{"key":"2024080105203385000_65.8.1217.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262096"},{"key":"2024080105203385000_65.8.1217.29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2020.06.040","article-title":"Fibroblast activation protein (FAP) specific PET for advanced target volume delineation in glioblastoma","volume":"150","author":"Windisch","year":"2020","journal-title":"Radiother Oncol."},{"key":"2024080105203385000_65.8.1217.30","first-page":"4050","article-title":"Fibroblast activation protein (FAP) as a target for radioligand therapy in glioblastoma","volume":"63","author":"Jeanjean","year":"2022","journal-title":"J Nucl Med."},{"key":"2024080105203385000_65.8.1217.31","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U"},{"key":"2024080105203385000_65.8.1217.32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s13277-012-0638-2","article-title":"High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis","volume":"34","author":"Wikberg","year":"2013","journal-title":"Tumour Biol."},{"key":"2024080105203385000_65.8.1217.33","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23368"},{"key":"2024080105203385000_65.8.1217.34","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2012-200909"},{"key":"2024080105203385000_65.8.1217.35","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e31816618ce"},{"key":"2024080105203385000_65.8.1217.36","doi-asserted-by":"crossref","first-page":"e68782","DOI":"10.1371\/journal.pone.0068782","article-title":"IDH1\/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis","volume":"8","author":"Zou","year":"2013","journal-title":"PLoS One."},{"key":"2024080105203385000_65.8.1217.37","first-page":"4767","article-title":"Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model","volume":"62","author":"Cheng","year":"2002","journal-title":"Cancer Res."},{"key":"2024080105203385000_65.8.1217.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2009.04.007"},{"key":"2024080105203385000_65.8.1217.39","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.6.11.4874"},{"key":"2024080105203385000_65.8.1217.40","first-page":"1639","article-title":"A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer","volume":"9","author":"Scott","year":"2003","journal-title":"Clin Cancer Res."},{"key":"2024080105203385000_65.8.1217.41","doi-asserted-by":"publisher","DOI":"10.1159\/000069863"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.267151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T12:21:44Z","timestamp":1722514904000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.267151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,1]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.2967\/jnumed.123.267151"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.267151","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]}}}